These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 10735364)

  • 1. Frontline immunochromatographic device for on-site urine testing of amphetamines: laboratory validation using authentic specimens.
    Beck O; Kraft M; Moeller MR; Smith BL; Schneider S; Wennig R
    Ann Clin Biochem; 2000 Mar; 37 ( Pt 2)():199-204. PubMed ID: 10735364
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A broad spectrum immunoassay using fluorescence polarization for the detection of amphetamines in urine.
    Turner GJ; Colbert DL; Chowdry BZ
    Ann Clin Biochem; 1991 Nov; 28 ( Pt 6)():588-94. PubMed ID: 1776809
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Simultaneous determination of amphetamines and amphetamine-derived designer drugs in human urine by GC-MS.
    Maresová V; Chadt J; Prikryl L
    Neuro Endocrinol Lett; 2006 Dec; 27 Suppl 2():121-4. PubMed ID: 17159795
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of ephedrine, pseudoephedrine and phenylpropanolamine concentrations in human urine samples and a comparison of the specificity of DRI amphetamines and Abuscreen online (KIMS) amphetamines screening immunoassays.
    Stout PR; Klette KL; Horn CK
    J Forensic Sci; 2004 Jan; 49(1):160-4. PubMed ID: 14979364
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The detection of amphetamines in urine samples using immunochromatographic test strips].
    Shanin IA; Khan OIu; Petukhov AE; Smirnov AV; Eremin SA
    Sud Med Ekspert; 2012; 55(4):33-7. PubMed ID: 23008958
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The urinary screening and identification of amphetamines in clinical toxicology laboratory--VGH].
    Lin WL; Deng JF; Chou LJ; Hung DZ; Tsai WJ
    Zhonghua Yi Xue Za Zhi (Taipei); 1991 Oct; 48(4):305-9. PubMed ID: 1659927
    [TBL] [Abstract][Full Text] [Related]  

  • 7. On-line derivatization gas chromatography with furan chemical ionization tandem mass spectrometry for screening of amphetamines in urine.
    Tzing SH; Ghule A; Liu JY; Ling YC
    J Chromatogr A; 2006 Dec; 1137(1):76-83. PubMed ID: 17034801
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of the Triage PPY on-site testing device for the detection of dextropropoxyphene in urine.
    Poklis A; Poklis JL; Tarnai LD; Backer RC
    J Anal Toxicol; 2004 Sep; 28(6):485-8. PubMed ID: 15516300
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lack of Detection of New Amphetamine-Like Drugs Using Conventional Urinary Immunoassays.
    Begeman A; Franssen EJF
    Ther Drug Monit; 2018 Feb; 40(1):135-139. PubMed ID: 29194289
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development and evaluation of an improved method for screening of amphetamines.
    Shindelman J; Mahal J; Hemphill G; Pizzo P; Coty WA
    J Anal Toxicol; 1999 Oct; 23(6):506-10. PubMed ID: 10517558
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of a direct high-capacity target screening approach for urine drug testing using liquid chromatography-time-of-flight mass spectrometry.
    Saleh A; Stephanson NN; Granelli I; Villén T; Beck O
    J Chromatogr B Analyt Technol Biomed Life Sci; 2012 Nov; 909():6-13. PubMed ID: 23153637
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An evaluation of the OnTrak Testcup-er on-site urine drug-testing device for drugs commonly encountered from emergency departments.
    Peace MR; Poklis JL; Tarnai LD; Poklis A
    J Anal Toxicol; 2002 Oct; 26(7):500-3. PubMed ID: 12423007
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical issues associated with urine testing of substances of abuse.
    Eskridge KD; Guthrie SK
    Pharmacotherapy; 1997; 17(3):497-510. PubMed ID: 9165553
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Performance characteristics of DRI, CEDIA, and REMEDi systems for preliminary tests of amphetamines and opiates in human urine.
    Huang MK; Dai YS; Lee CH; Liu C; Tsay WI; Li JH
    J Anal Toxicol; 2006; 30(1):61-4. PubMed ID: 16620534
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Precision and comparability of Abuscreen OnLine assays for drugs of abuse screening in urine on Hitachi 917 with other immunochemical tests and with GC/MS.
    Boettcher M; Haenseler E; Hoke C; Nichols J; Raab D; Domke I
    Clin Lab; 2000; 46(1-2):49-52. PubMed ID: 10745981
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison between drug screening by immunoassay and ultra-high performance liquid chromatography/high-resolution time-of-flight mass spectrometry in post-mortem urine.
    Sundström M; Pelander A; Ojanperä I
    Drug Test Anal; 2015 May; 7(5):420-7. PubMed ID: 24953563
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dimethylamylamine: a drug causing positive immunoassay results for amphetamines.
    Vorce SP; Holler JM; Cawrse BM; Magluilo J
    J Anal Toxicol; 2011 Apr; 35(3):183-7. PubMed ID: 21439156
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Validation of an ELISA-based screening assay for the detection of amphetamine, MDMA and MDA in blood and oral fluid.
    Laloup M; Tilman G; Maes V; De Boeck G; Wallemacq P; Ramaekers J; Samyn N
    Forensic Sci Int; 2005 Oct; 153(1):29-37. PubMed ID: 15922530
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Crossreactivity of bupropion metabolite with enzyme-linked immunosorbent assays designed to detect amphetamine in urine.
    Reidy L; Walls HC; Steele BW
    Ther Drug Monit; 2011 Jun; 33(3):366-8. PubMed ID: 21436763
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection of the synthetic drug 4-fluoroamphetamine (4-FA) in serum and urine.
    Röhrich J; Becker J; Kaufmann T; Zörntlein S; Urban R
    Forensic Sci Int; 2012 Feb; 215(1-3):3-7. PubMed ID: 21543168
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.